Science Explorer Back to mapMap
Discussion
Researcher · Rocky Mountain Cancer Centers · United States

Robert M. Jotte

Robert M. Jotte publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0003-3920-0731 OpenAlex
World rank
#560,603
of 7,710,434 ranked researchers
Rank in United States
#193,423
of 1,627,098
Works
186
Citations
15k
Citations per work
80.1
h-index
37
i10-index 75Top 7.4% in Oncology
Robert M. Jotte

What does Robert M. Jotte research?

Robert M. Jotte's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (4%).

Health Sciences: 130 works · 69.9% of their workMedicine: 130 works · 69.9% of their workOncology: 73 works · 39.2% of their workPulmonary and Respiratory Medicine: 51 works · 27.5% of their workEpidemiology: 6 works · 3.2% of their workLife Sciences: 34 works · 18.3% of their workBiochemistry, Genetics and Molecular Biology: 27 works · 14.5% of their workMolecular Biology: 19 works · 10.2% of their workCancer Research: 8 works · 4.3% of their workImmunology and Microbiology: 7 works · 3.8% of their workImmunology: 7 works · 3.8% of their workEverything else: 22 works · 11.8% of their workTHEIR WORKRobert M. Jotte186works
Life Sciences18%Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13069.9%
    1. Biochemistry, Genetics and Molecular Biology2714.5%
    2. Immunology and Microbiology73.8%
  3. Everything else2211.8%
  1. 1Oncology39% of their works
  2. 2Pulmonary and Respiratory Medicine28% of their works
  3. 3Molecular Biology10% of their works
  4. 4Cancer Research4% of their works
  5. 5Immunology4% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Robert M. Jotte's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Clinical Trials1502 topics
  2. Targeted Therapy1502 topics
  3. Chemotherapy1144 topics
  4. ALK Inhibitors901 topic
  5. EGFR Mutations901 topic
  6. Genomic Profiles601 topic
  7. Small-Cell Lung Cancer601 topic
  8. Immune Checkpoint Blockade541 topic
  9. PD-1 and PD-L1541 topic
  10. Cetuximab191 topic
  11. KRAS Mutations191 topic
  12. CT Screening181 topic
  13. Lung Cancer181 topic
  14. Chemotherapy-Induced Peripheral Neuropathy171 topic
  15. DNA171 topic
  16. Taxanes171 topic
  17. Topoisomerases171 topic
  18. Neuroendocrine Tumors131 topic
  19. Pancreatic Neuroendocrine Tumors131 topic

Where does Robert M. Jotte work?

Robert M. Jotte's main affiliation in the publication record is Rocky Mountain Cancer Centers, United States.

How many publications and citations does Robert M. Jotte have?

OpenAlex counts 186 works and 14,892 citations for Robert M. Jotte, an h-index of 37, ranking #560,603 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert M. Jotte. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.